Moneycontrol PRO
HomeNewsBusinessDaikin to go ahead with its plan for third manufacturing unit in India

Daikin to go ahead with its plan for third manufacturing unit in India

Daikin Air conditioning India, a wholly-owned subsidiary of Japan-based Daikin Industries, said the company is ready to take advantage of the – Phased Manufacturing Program (PMP), under which the government has announced incentives for manufactures to promote "Make in India".

June 11, 2020 / 14:58 IST

Notwithstanding the COVID-19 disruption, Japanese air conditioner maker Daikin will go ahead with its investment plan for setting up a third manufacturing unit in India, in a bid to augment the local production capacity, a top company official said on Thursday.

Daikin Air conditioning India, a wholly-owned subsidiary of Japan-based Daikin Industries, said the company is ready to take advantage of the – Phased Manufacturing Program (PMP), under which the government has announced incentives for manufactures to promote "Make in India".

The company, which has plans to set up a third manufacturing unit in South India, would make an announcement regarding it very soon after finalising the site. This new plant would cater to the African markets besides the domestic one.

"Daikin is ready to take the advantage of PMP and remain committed to invest in the third manufacturing unit to augment local production capacity," Daikin Air conditioning India MD & CEO Kanwal Jeet Jawa told PTI.

Jawa, who is also the first Indian on the board of Daikin Industries, said PMP could be game-changer and is a "bold and pro-active step" from the government to boost Indian manufacturing capabilities and support the economy with more jobs, consumption, and trade.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Daikin India had already shared its intent on the local value addition during the past few months.

The company sees COVID-19 as a short-term disruption and believes in the long-term potential of the Indian market.

"Considering China produces more than 100 million ACs per year, the Indian market of 6.5 million units bears a great potential, if a comprehensive plan can be implemented to support local manufacturing and grow the market," he said.

Jawa further said around 40 percent sales of the air conditioners are in the month of March to June and almost half of that has gone due to COVID-19 related disruption in the market.

"The AC industry, like many others, is also impacted in terms of – demand fulfillment, manufacturing and after-sales service leading to a 30 percent sales drop during the lockdown," he said adding "we have a complete washout in the month of April. We have some billings in the month, only to some COVID-19 hospitals and centers".

However, Jawa is hopeful and expects a revival in June.

"With the late summer and pent-up demand, we are witnessing consumers returning to buy ACs. With gradually opening of the economy many small and medium businesses are now in need of air-conditioning like before, hinting towards a steady growth," he said adding that normal growth for the industry would return by the last quarter of FY21.

While talking about FY20, Jawa said it was a good year for Daikin India, but towards the end, it had to face challenges owing to COVID-19 situation. "Last year was very good and we had recorded a net sales of around Rs 4,200 crore," he said.

The company, which has recorded a net sale of Rs 3,250 crore in FY19 along with a CAGR of 118 percent, has invested around Rs 2,000 crore in India so far.

Daikin Air conditioning India has two manufacturing units and one Research and development (R&D) centre at Neemrana, Rajasthan.

Japan-based Daikin Industries, is one of the leading global manufacturers of both commercial and residential air-conditioning systems.

PTI
first published: Jun 11, 2020 02:52 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347